4D IMRT: Stereotactic body radiotherapy for lung cancer

Information

  • Research Project
  • 8388775
  • ApplicationId
    8388775
  • Core Project Number
    R01CA093626
  • Full Project Number
    4R01CA093626-10
  • Serial Number
    093626
  • FOA Number
    PA-07-070
  • Sub Project Id
  • Project Start Date
    7/1/2001 - 22 years ago
  • Project End Date
    11/30/2013 - 10 years ago
  • Program Officer Name
    CAPALA, JACEK
  • Budget Start Date
    12/1/2012 - 11 years ago
  • Budget End Date
    11/30/2013 - 10 years ago
  • Fiscal Year
    2013
  • Support Year
    10
  • Suffix
  • Award Notice Date
    11/27/2012 - 11 years ago
Organizations

4D IMRT: Stereotactic body radiotherapy for lung cancer

DESCRIPTION (provided by applicant): There are several trends in lung cancer patient management, all leading to an increase in the number of patients being treated with stereotactic body radiotherapy (SBRT). The trends are: (1) increased lung cancer detection through screening programs; (2) promising results of lung SBRT trials using current techniques and technology; and (3) comparable results of SBRT to surgery for medically operable patients leading to open phase II and III trials. Lung SBRT is an emerging technique utilizing high precision and large radiation doses to ablate lung tumor tissue. Despite excellent local control in most studies, the cost of using ablative radiation doses with current radiotherapy technology is morbidity, and in some cases mortality. The research proposed for this grant aims to significantly reduce the toxicity of lung SBRT through several technological developments and associated investigations. First we will solve the four-dimensional constrained treatment planning problem in collaboration with optimization experts; improved treatment plans will be created by including anatomic changes with time as an additional degree of freedom in the optimization. Second, we will combine two intra-treatment imaging modalities, external and internal, to obtain a real-time estimate of the target motion throughout the radiation treatment. Third, this position estimate will be used to direct beams of intensity modulated radiation to moving tumors in real time to offer unprecedented treatment conformality and normal tissue dose reduction. Fourth, a respiratory audiovisual biofeedback tool will be developed in collaboration with a musician and design expert. This tool will improve respiratory regularity for lung SBRT patients and thus decreasing PET/CT artifacts and target delineation errors on PET/CT scans and facilitating improved treatment beam-tumor alignment during radiation delivery. Such a comprehensive and multidisciplinary approach to manage tumor motion will offer the radiation oncology team superior radiation beam-tumor targeting and conformality methods to treat early stage lung cancer patients. We expect the research will ultimately result in a measurable improvement in treatment outcome and have a widespread impact on lung cancer management.

IC Name
NATIONAL CANCER INSTITUTE
  • Activity
    R01
  • Administering IC
    CA
  • Application Type
    4
  • Direct Cost Amount
    240336
  • Indirect Cost Amount
    5406
  • Total Cost
    245742
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    395
  • Ed Inst. Type
  • Funding ICs
    NCI:245742\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    RTB
  • Study Section Name
    Radiation Therapeutics and Biology Study Section
  • Organization Name
    UNIVERSITY OF SYDNEY
  • Organization Department
  • Organization DUNS
    752389338
  • Organization City
    SYDNEY
  • Organization State
  • Organization Country
    AUSTRALIA
  • Organization Zip Code
    2006
  • Organization District
    AUSTRALIA